Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/1/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. David J. Enscore PhD

Wrong Dr. David J. Enscore PhD?

Principal Scientist

Phone: (678) ***-****  HQ Phone
4P Therapeutics LLC
9005 Westside Parkway
Alpharetta, Georgia 30009
United States

Company Description: 4P Therapeutics is focused on research and development of novel transdermal products. 4P Therapeutics develops products that meet the needs of patients, physicians...   more
Background

Employment History

  • Senior Vice President, Product Research and Development
    Altea Therapeutics Corporation
  • Senior Vice President of Product Devt
    Altea Therapeutics Corporation
  • Vice President of Research and Development
    Micell Technologies Inc
  • President and Head of Research and Development
    Spherics , Inc.
  • Vice President, Research and Development
    Spherics , Inc.
  • Senior Research and Development Positions
    Spherics , Inc.
  • Vice President, Research, Development and Drug Delivery
    Focal, Inc.
  • Senior Research and Development Positions
    Focal, Inc.
  • ALZA Corporation

Board Memberships and Affiliations

Education

  • Ph.D.
  • PhD , Chemical Engineering
    North Carolina State University
  • BS
    North Carolina State University
18 Total References
Web References
Leadership - 4P THERAPEUTICS - Transdermal Research and Development
www.4ptherapeutics.com, 1 Mar 2014 [cached]
David Enscore, Ph.D. - Principal Scientist
David J. Enscore advises 4P Therapeutics technology selection, product design goals, and analyzes results from product development studies. Over the last several years, he has provided product development direction to the pharmaceutical and medical device industries on a consulting basis. His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent.
He has served as an expert witness in several patent litigation cases involving transdermal technology. Prior to starting his consulting business, Dr. Enscore was Senior Vice President, Product Research and Development at Altea Therapeutics and was responsible for all product development activities including pharmaceutical science, engineering, clinical R&D, quality assurance, and regulatory affairs. Before joining Altea Therapeutics, he held senior R&D positions at Spherics, Incorporated, an advanced oral drug delivery company and Focal, Incorporated, a company that developed resorbable tissue sealants.
Prior to this, Dr. Enscore worked extensively in transdermal drug delivery, in various scientific and management positions, at Alza Corporation. At Alza, he lead the development of Nicoderm® CQ (transdermal nicotine), the second generation testosterone transdermal system (Testoderm® TTS), and the Actisite® tetracycline periodontal fiber. He has been granted 25 U.S. patents in controlled drug delivery and biodegrabable polymers. Dr. Enscore received a BS and a PhD in Chemical Engineering, with a minor in Polymer Science, from North Carolina State University.
Altea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product Development
biz.yahoo.com, 11 Dec 2003 [cached]
Altea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product DevelopmentAltea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product Development
...
Altea Therapeutics Appoints Senior R&D Executive Dr. David J. Enscore to Lead Product Development
...
TUCKER, Ga.--(BUSINESS WIRE)--Dec. 11, 2003--Altea Therapeutics has appointed David J. Enscore, PhD, as Senior Vice President for Product Research & Development.Dr. Enscore is responsible for leading all of the Company's pharmaceutical product research and development activities.The Company's lead clinical products are a daily insulin skin patch for treating individuals with diabetes and a hydromorphone skin patch for the controllable management of severe acute and chronic pain.
David Enscore has had an extensive career in the development of novel therapeutic products.He was previously at ALZA as Executive Director, Transdermal Product Development where he managed the development of four commercial controlled release pharmaceuticals, including NICODERM CQ (Transdermal Nicotine).More recently he was Vice President for Research & Development at Focal, Inc., responsible for the definition, development and market introduction of two surgical sealant products: FocalSeal-L and FocalSeal-S.He joins Altea Therapeutics from Spherics, Inc., a drug delivery company based in Lincoln, RI, where was President and Head of Research & Development.Dr. Enscore is an Inventor on 24 U.S. patents in drug delivery and medical devices.
"David's appointment will strengthen both our pharmaceutical development capabilities and our project management needs as we transition from a technology-based company to one developing high-value pharmaceutical products" said Eric Tomlinson, D.Sc., Ph.D., the Company's Chief Executive Officer."
...
It offers a painless alternative to needle injections while providing controllable drug delivery," said Dr. Enscore.
Feinstein Partners, Inc.
www.prnewswire.com, 1 Dec 2004 [cached]
David J. Enscore, Ph.D. Joins Spherics, Inc. as Vice President, Research and Development
David Enscore, ...
www.4ptherapeutics.com, 12 June 2012 [cached]
David Enscore, Ph.D. Senior Scientific Advisor
David J. Enscore advises 4P Therapeutics technology selection, product design goals, and analyzes results from product development studies. Over the last several years, he has provided product development direction to the pharmaceutical and medical device industries on a consulting basis. His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent. He has served as an expert witness in several patent litigation cases involving transdermal technology. Prior to starting his consulting business, Dr. Enscore was Senior Vice President, Product Research and Development at Altea Therapeutics and was responsible for all product development activities including pharmaceutical science, engineering, clinical R&D, quality assurance, and regulatory affairs. Before joining Altea Therapeutics, he held senior R&D positions at Spherics, Incorporated, an advanced oral drug delivery company and Focal, Incorporated, a company that developed resorbable tissue sealants. Prior to this, Dr. Enscore worked extensively in transdermal drug delivery, in various scientific and management positions, at Alza Corporation. At Alza, he lead the development of Nicoderm® CQ (transdermal nicotine), the second generation testosterone transdermal system (Testoderm® TTS), and the Actisite® tetracycline periodontal fiber. He has been granted 25 U.S. patents in controlled drug delivery and biodegrabable polymers. Dr. Enscore received a BS and a PhD in Chemical Engineering, with a minor in Polymer Science, from North Carolina State University.
GeorgiaBio: Altea Therapeutics Forms Premier Scientific Advisory Board
www.gabio.org, 8 Aug 2008 [cached]
David J. Enscore, PhD managed the commercial development of four controlled release pharmaceuticals while at ALZA, a leading drug delivery company subsequently acquired by Johnson & Johnson. He was formerly SVP Product Research and Development at Altea Therapeutics and is an inventor on 25 U.S. patents in drug delivery and medical devices.
Other People with the name "Enscore":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.